Read + Share
Amedeo Smart
Independent Medical Education
Venkat S, Zeeman M, Hart A, Bhagat S, et al. Serum Protein Profiles Differ with Adalimumab and Ustekinumab Treatment in Moderately to Severely Active Crohn's Disease. J Crohns Colitis 2025 Nov 19:jjaf197. doi: 10.1093.PMID: 41258994
Email
LinkedIn
Privacy Policy